Ruby Cheung
About Ruby Cheung
Ruby Cheung is an Associate Scientist at Sangamo Therapeutics, Inc. in Richmond, California, with over a decade of experience in the biotechnology field, specializing in immunogenicity and biomarker assay development.
Work at Sangamo Therapeutics
Ruby Cheung has been serving as an Associate Scientist at Sangamo Therapeutics, Inc. since 2019. Located in Richmond, California, she has contributed to various projects over her five-year tenure. Her role involves applying her expertise in immunogenicity and pharmacokinetic biomarker assay development, validation, outsourcing, and monitoring. This position allows her to leverage her extensive background in study management and in vivo modeling.
Education and Expertise
Ruby Cheung holds a Bachelor's degree in Molecular and Cell Biology and Music (Honors) from the University of California, Berkeley, completed in 2005. She further advanced her education by obtaining a Master's degree in Biotechnology from The Johns Hopkins University between 2012 and 2014. Her academic background supports her expertise in immunogenicity and pharmacokinetic biomarker assay development, as well as in vivo modeling for oncology and autoimmune diseases.
Background
Ruby Cheung has a diverse professional background in the biotechnology and pharmaceutical sectors. She began her career with internships at Bio-Rad Laboratories and Berlex Biosciences. She then progressed through various roles, including Research Associate positions at Cytokinetics and Five Prime Therapeutics, before joining BioMarin Pharmaceutical Inc. as a Senior Research Associate. Her experience spans over a decade in research and development, focusing on study management and protocol execution.
Achievements
Throughout her career, Ruby Cheung has contributed to significant projects, particularly in the areas of immunogenicity and pharmacokinetic biomarker assay development. Her work has supported IND submissions, showcasing her involvement in critical phases of drug development. Her strong background in study management, including protocol design and report finalization, has been instrumental in her roles across various organizations.